Evidence map›Paper›PMID 30530605›Full record

ArticleAntimicrobial agents and chemotherapy2019

Diverse Vectors and Mechanisms Spread New Delhi Metallo-β-Lactamases among Carbapenem-Resistant

Nicole Pecora, Xiaomin Zhao, Kathleen Nudel, Maria Hoffmann, Ning Li, Andrew B Onderdonk, Deborah Yokoe, Eric Brown, Marc Allard, Lynn Bry

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Approaching pathogenicbioRxiv : the preprint server for biology · 2024
    Article
  7. Genomic Insights Into the Mechanism of Carbapenem Resistance Dissemination in Enterobacterales From a Tertiary Public Heath Setting in South Asia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular Epidemiology of Carbapenemases inAntibiotics (Basel, Switzerland) · 2020
    Review
  14. Review
  15. Carbapenem-ResistantInfection and drug resistance · 2020
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Nicole Pecora *Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA Nicole_pecora@urmc.rochester.edu lbry@bwh.harvard.edu.
Xiaomin Zhao *Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kathleen Nudel *Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Maria HoffmannDivision of Microbiology, Office of Regulatory Science, Center for Food Safety and Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.
Ning LiMassachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Andrew B OnderdonkClinical Microbiology Laboratory, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Deborah YokoeDivision of Infectious Diseases, Department of Medicine, UCSF School of Medicine, San Francisco, California, USA.
Eric BrownDivision of Microbiology, Office of Regulatory Science, Center for Food Safety and Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.
Marc AllardDivision of Microbiology, Office of Regulatory Science, Center for Food Safety and Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.
Lynn BryMassachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA Nicole_pecora@urmc.rochester.edu lbry@bwh.harvard.edu.
Brigham and Women's Hospital · USHarvard University · USCenter for Food Safety and Applied Nutrition · USUnited States Food and Drug Administration · USUniversity of California, San Francisco · US

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WAYNE I LENCER · 1986 to 2026
$32.4M
VASCULAR, PULMONARY AND RENAL INJURYT32HL007627 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI GIMBRONE, MICHAEL A, MITCHELL, RICHARD N · 1985 to 2019
$12.7M
NHLBI NIH HHS T32 HL007627NIDDK NIH HHS P30 DK034854
6 · The paper itself

Abstract

New Delhi metallo-beta-lactamases (NDMs) are an uncommon but emerging cause of carbapenem resistance in the United States. Genomic factors promoting their domestic spread remain poorly characterized. A prospective genomic surveillance program among Boston-area hospitals identified multiple new occurrences of NDM-carrying strains of

Indexed as

Anti-Bacterial Agentsbeta-LactamasesBostonCarbapenem-Resistant EnterobacteriaceaeCarbapenemsConjugation, GeneticDrug Resistance, BacterialEnterobacter cloacaeEscherichia coliGene Transfer, HorizontalHumansMultilocus Sequence TypingPolymorphism, Single NucleotideAnti-Bacterial Agentsbeta-lactamase NDM-1beta-LactamasesCarbapenemsantibiotic resistancecarbapenem resistanceCREgenomicsNDM

Identifiers

PMID30530605
PMCPMC6355588
OpenAlexW2905411220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.